Latest Liver function tests Stories
GOTHENBURG, Sweden, February 5, 2015 /PRNewswire/ -- Albireo today announced initiation of a phase II trial with A4250, the company's lead compound for cholestatic liver
In preclinical studies, CF102 induces hepatocyte proliferation resulting in improved liver status PETACH TIKVA, Israel, Sept.
TEL AVIV, Israel, July 22, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
CAMEO Phase 2 Clinical Trial of LUM001 Now Enrolling Adults with Primary Sclerosing Cholangitis SAN DIEGO, May 9, 2014 /PRNewswire/ --
Results from an international Phase III study presented today at the International Liver CongressTM 2014 have shown obeticholic acid (OCA) given to patients suffering from Primary Biliary Cirrhosis (PBC) who previously had an inadequate response to, or have been unable to tolerate ursodeoxycholic acid (UDCA), produced meaningful biochemical and clinical improvements.
Liver Cirrhosis Bible & Ezra Protocol, created by Debrea Elkin, is a brand new product that uncovers useful tips on how to cure liver cirrhosis disease.
Funding to support clinical development of treatments for rare cholestatic liver diseases and nonalcoholic steatohepatitis SAN DIEGO, March 11, 2014 /PRNewswire/ -- Lumena Pharmaceuticals
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.